Deficient tear secretion

Active Ingredient: Acetylcysteine

Indication for Acetylcysteine

Population group: only adults (18 - 65 years old)

Acetylcysteine is suitable for the relief of dry eye syndromes associated with deficient tear secretion, impaired or abnormal mucus production.

For this indication, competent medicine agencies globally authorize below treatments:

3-8 drops in 3-4 divided doses daily

Route of admnistration

Ophthalmic

Defined daily dose

3 - 8 {drops}

Dosage regimen

From 1.5 To 4 {drops} 2 time(s) per day every day

Detailed description

The usual dose is 1 or 2 drops instilled into the affected eye(s) 3 or 4 times daily.

Active ingredient

Acetylcysteine

Acetylcysteine is N-acetyl derivative of cysteine. Used as a mucolytic agent to reduce the viscosity of mucous secretions.

Read more about Acetylcysteine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.